Medical Diagnostics Patenting Faces Increased Challenges in Canada

August 11, 2016

In the August/September issue of Biotechnology Focus Magazine, Melanie Szweras and Carmela De Luca discuss recent changes in patent office examination policy which may have negative long term impacts on the innovative diagnostics industry in Canada.

To read the article please download the PDF below.

Information on this website is for information only. It is not, and should not be taken as, legal advice. You should not rely on, or take or not take any action, based upon this information. Professional legal advice should be promptly obtained. Bereskin & Parr LLP professionals will be pleased to advise you.

Author(s):

Melanie Szweras Melanie Szweras
B.Sc., Ph.D. (Genetics), LL.B.
Partner
Carmela De Luca Carmela De Luca
B.Sc. (Hons. Biochem., Co-op), Ph.D. (Exp. Med.), J.D.
Partner